RARA and central nervous system cancer: Therefore, we hypothesize that the inherent resistance to retinoic acid in glioma cells may be due to a block in retinoid receptor degradation pathway that occurs after sumo modification, but before the RARA and RXRA proteins are delivered to the proteasome.